New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 25, 2013
11:28 EDTEBAY, BLUE, AMZN, OSTKAmazon hits 52-week high after mixed results, positive analyst commentary
Shares of online retailer Amazon (AMZN) are rallying after the company reported mixed third quarter results that were well-received by many analysts. WHAT'S NEW: Last night, Amazon reported Q3 EPS of (9c) and revenue of $17.09B. Analysts' consensus expectations were for EPS of (9c) and revenue of $16.76B. The company forecast that its fourth quarter revenue would be $23.5B-$26.5B, versus analystsí consensus estimate of $25.89B. ANALYST REACTION: This morning, eight firms raised their price targets on Amazonís shares. In addition, Raymond James upgraded the shares to Strong Buy from Market Perform, citing revenue acceleration in the U.S., strong growth of the company's cloud computing service, and its belief that the company's margins will rise in 2014. The firm has a price target of $446 on the stock. PRICE ACTION: In late morning trading, Amazon rose $28.16, or 8.5%, to $360.21 on more than twice its average daily trading volume. Earlier in the session, the stock hit a new 52-week high of $368.40, and itís up approximately 45% year to date,. OTHERS TO WATCH: Other companies in the online retail space include EBAY (EBAY) , Overstock.com (OSTK), and Blue Nile (BLUE).
News For AMZN;EBAY;OSTK;BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
December 9, 2014
14:12 EDTBLUEbluebird bio soars after announcing drug trial results
Subscribe for More Information
12:25 EDTBLUEOn The Fly: Midday Wrap
Subscribe for More Information
10:19 EDTBLUEHigh option volume stocks
Subscribe for More Information
10:08 EDTBLUEHigh option volume stocks
Subscribe for More Information
09:27 EDTBLUEbluebird bio price target raised to $90 from $50 at Roth Capital
Roth Capital hiked its price target on bluebird after the company reported favorable data for its LentiGlobin drug product at ASH. The firm keeps a Buy rating on the shares.
09:21 EDTBLUEOn The Fly: Pre-market Movers
UP AFTER EARNINGS: AutoZone (AZO), up 3.8%... Burlington Stores (BURL), up 3.3%. ALSO HIGHER: bluebird bio (BLUE), up 56.5% after price target raised at Piper Jaffray and SunTrust... Camtek (CAMT), up 6.7% after being awarded a $2.8M order from a semiconductor manufacturer... PDC Energy (PDCE), up 5.8% after providing fiscal 2015 production guidance... Mast Therapeutics (MSTX), up 3.1% after reporting that it will begin recruiting patients for MST-188 study in first half of fiscal 2015... Idera Pharmaceuticals (IDRA), up 1.4% after announcing data for its lead product candidate, IMO-8400. DOWN AFTER EARNINGS: UTi Worldwide (UTIW), down 10.8%... CONN'S (CONN), down 35.9% after reporting third quarter results, withdrawing fiscal 2015 guidance, stating that there is no timetable set for completion of strategic alternatives, and announcing the departure of its CFO. ALSO LOWER: Apple (AAPL), down 1.6% after Pacific Crest says that weak iPad demand could cause Apple to miss estimates and following a Wall Street Journal report that a judge denied Apple's efforts to throw out iPod pricing lawsuit... Allied Nevada Gold (ANV), down 30.1% after announcing pricing of common stock and warrant offering... United Continental (UAL), down 2.7% after reporting November traffic.
07:55 EDTAMZNAmazon.com continuing to gain share, says Pacific Crest
After conducting a consumer technology survey, Pacific Crest reports that 81% of respondents plan to shop at Amazon this holiday, while 31% plan to do most or nearly all of their online holiday shopping on the website. The firm thinks the company is continuing to gain share and it recommends buying the stock.
07:35 EDTBLUEbluebird bio price target raised to $115 from $57 at SunTrust
Subscribe for More Information
06:45 EDTBLUEbluebird bio price target raised to $112 from $52 at Piper Jaffray
Piper Jaffray more than doubled its price target for bluebird bio shares to $112 saying the company's LentiGlobin program is advancing in sickle cell anemia. Piper believes bluebird "remains positioned for extraordinary outperformance in 2015." The firm thinks the data presented at the American Society of Hematology are an "impressive accomplishment for the gene therapy field" as well as bluebird's lentivirus platform. It keeps an Overweight rating on the stock. Shares of the clinical-stage biotechnology company rallied yesterday $4.18 to $48.89 and are indicated up $21.11 in pre-market trading to $70.
06:29 EDTAMZNAmazon warns of moving more drone research abroad, WSJ reports
Subscribe for More Information
06:23 EDTAMZNAmazon.com testing faster deliveries through bikes, drones, WSJ reports
Subscribe for More Information
06:16 EDTAMZNAmazon unveils 'Make an Offer' for customers to negotiate lower prices
Amazon.com has announced the "Make an Offer" experience that allows customers to negotiate even lower prices on thousands of items. Expanding on Amazonís traditional fixed price model, the new pricing feature allows customers to offer to buy items at even lower prices. If agreed upon, customers can then purchase the items at a savings from the listed price. To start, more than 150,000 items from sellers on Amazon are enabled with the "Make an Offer" experience across Sports and Entertainment Collectibles, Collectible Coins and Fine Art. The new feature will expand to hundreds of thousands of items from sellers in 2015. The "Make an Offer" feature is not an auction format. All negotiations are 1:1 and private between individual customers and sellers. A seller is able to accept a customerís offer at any time. The intention is to lower prices, and a customer negotiating with a seller will never pay more than the listed price.
05:34 EDTAMZN, EBAYChannelAdvisor says Amazon November SSS up 35.7%, eBay up 9.8%
Subscribe for More Information
December 8, 2014
17:48 EDTBLUEbluebird bio says first four patients treated with LentiGlobin transfusion-free
bluebird bio announced data from eight subjects treated with LentiGlobin BB305 drug product. In the first four subjects, each of whom had at least three months of follow up, treatment with LentiGlobin BB305 drug product resulted in sufficient hemoglobin production to reduce or eliminate the need for transfusion support among patients with beta-thalassemia major who would otherwise require chronic blood transfusions. These data include the first five subjects treated in bluebird bioís ongoing Phase 1/2 Northstar Study and the first three subjects from its HGB-205 study. These studies include the first subjects with the beta-0/beta-0 genotype of beta-thalassemia major treated with LentiGlobin BB305 drug product and the first subject with sickle cell disease treated with gene therapy. These data are being presented today at the 56th Annual Meeting of the American Society of Hematology in San Francisco.
16:00 EDTAMZNOptions Update; December 8, 2014
Subscribe for More Information
13:52 EDTEBAYeBay advances slightly in down tape after Stifel upgrades shares
Shares of eBay (EBAY) are rising slightly in a down market after research firm Stifel upgraded the stock to Buy from Hold. WHAT'S NEW: The risk/reward ratio on eBay appears to be favorable, Stifel analyst Scott Devitt wrote in a note to investors today. In the most likely scenario for the company, the shares could increase as high as about $65 from their current level of around $55, but are unlikely to drop much below $50, Devitt believes. In a possible bullish scenario, the shares could go up to $75, the analyst stated. The spin off of eBay's PayPal business, expected to occur within nine months, should be a significant catalyst for the stock, while the gross merchandise volume generated by the company's marketplaces business should accelerate in the second half of next year, wrote Devitt. Marketplaces comparisons become easier starting in the second half of the year, the analyst explained. Additionally, eBay will begin to emphasize that the percentage of e-commerce transactions processed by PayPal is increasing, Devitt stated. Meanwhile, eBay's valuation is "compelling," and the upcoming spin-off reminds Devitt of the separation of Expedia (EXPE) and TripAdvisor (TRIP), which proved to be a positive catalyst, he wrote. Devitt set a $65 price target on the shares. PRICE ACTION: In mid-afternoon trading, eBay gained 17c, or 0.3%, to $54.97.
10:00 EDTEBAYOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Antero Resources (AR) upgraded to Buy from Neutral at Citigroup... Apache (APA) upgraded to Buy from Neutral at Citigroup... Applied Materials (AMAT) upgraded to Buy from Hold at Deutsche Bank... Arch Capital (ACGL) upgraded to Outperform from Market Perform at BMO Capital... CU Bancorp (CUNB) upgraded to Buy from Hold at Sandler O'Neill... Calpine (CPN) upgraded to Outperform from Neutral at Macquarie... Commerzbank (CRZBY) upgraded to Market Perform from Underperform at Keefe Bruyette... EastGroup Properties (EGP) upgraded to Neutral from Underperform at Credit Suisse... Enbridge Energy Management (EEQ) upgraded to Equal Weight at Morgan Stanley... Enbridge Energy (EEP) upgraded to Equal Weight from Underweight at Morgan Stanley... GasLog (GLOG) upgraded to Buy from Hold at Stifel... Hoegh LNG (HMLP) upgraded to Buy from Neutral at UBS... Illinois Tool Works (ITW) upgraded to Buy from Accumulate at Global Hunter... LaSalle Hotel (LHO) upgraded at Morgan Stanley... Lufthansa (DLAKY) upgraded to Buy from Neutral at Nomura... NASDAQ (NDAQ) upgraded to Outperform from Market Perform at Keefe Bruyette... Newfield Exploration (NFX) upgraded to Buy from Neutral at Citigroup... Omega Healthcare (OHI) upgraded to Buy from Hold at Jefferies... Orange SA (ORAN) upgraded to Conviction Buy from Neutral at Goldman... SM Energy (SM) upgraded to Outperform from Market Perform at BMO Capital... Southwest (LUV) upgraded at Goldman... TSMC (TSM) upgraded to Buy from Neutral at BofA/Merrill... United Technologies (UTX) upgraded at Bernstein... eBay (EBAY) upgraded to Buy from Hold at Stifel.
08:50 EDTAMZNAmazon increasing robot fulfilment use faster than expected, says Janney Capital
Subscribe for More Information
06:30 EDTAMZNAmazon's German workers strike again, WSJ reports
Subscribe for More Information
06:10 EDTEBAYeBay upgraded to Buy from Hold at Stifel
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use